Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 29;11(7):1906.
doi: 10.3390/jcm11071906.

Surgery for Liver Metastasis of Non-Colorectal and Non-Neuroendocrine Tumors

Affiliations

Surgery for Liver Metastasis of Non-Colorectal and Non-Neuroendocrine Tumors

Shadi Katou et al. J Clin Med. .

Abstract

Surgery has become well established for patients with colorectal and neuroendocrine liver metastases. However, the value of this procedure in non-colorectal and non-neuroendocrine metastases (NCRNNELMs) remains unclear. We analyzed the outcomes of patients that underwent liver surgery for NCRNNELMs and for colorectal liver metastases (CRLMs) between 2012 and 2017 at our institution. Prognostic factors of overall and recurrence-free survival were analyzed, and a comparison of survival between two groups was performed. Seventy-three patients (30 NCRNNELM and 43 CRLM) were included in this study. Although the mean age, extrahepatic metastases, and rate of reoperation were significantly different between the groups, recurrence-free survival was comparable. The 5-year overall survival rates were 38% for NCRNNELM and 55% for CRLM. In univariate analysis, a patient age of ≥60 years, endodermal origin of the primary tumor, and major complications were negative prognostic factors. Resection for NCRNNELM showed comparable results to resection for CRLM. Age, the embryological origin of the primary tumor, and the number of metastases might be the criteria for patient selection.

Keywords: colorectal liver metastases; liver metastases; liver resection; non-colorectal and non-neuroendocrine liver metastases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of patient inclusion.
Figure 2
Figure 2
Kaplan–Meier analysis of the overall and recurrence-free survival of patients with NCRNNE and CRLM.
Figure 3
Figure 3
Kaplan–Meier analysis of the age (above and below 60 years) and embryological origin of the primary tumor on overall survival of the patient with NCRNNE.
Figure 3
Figure 3
Kaplan–Meier analysis of the age (above and below 60 years) and embryological origin of the primary tumor on overall survival of the patient with NCRNNE.

References

    1. Abbas S., Lam V., Hollands M. Ten-year survival after liver resection for colorectal metastases: Systematic review and meta-analysis. ISRN Oncol. 2011;2011:763245. doi: 10.5402/2011/763245. - DOI - PMC - PubMed
    1. Creasy J.M., Sadot E., Koerkamp B.G., Chou J.F., Gonen M., Kemeny N.E., Balachandran V.P., Kingham T.P., DeMatteo R.P., Allen P.J., et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: What factors preclude cure? Surgery. 2018;163:1238–1244. doi: 10.1016/j.surg.2018.01.004. - DOI - PMC - PubMed
    1. Engstrand J., Nilsson H., Stromberg C., Jonas E., Freedman J. Colorectal cancer liver metastases—A population-based study on incidence, management and survival. BMC Cancer. 2018;18:78. doi: 10.1186/s12885-017-3925-x. - DOI - PMC - PubMed
    1. Hackl C., Neumann P., Gerken M., Loss M., Klinkhammer-Schalke M., Schlitt H.J. Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810. doi: 10.1186/1471-2407-14-810. - DOI - PMC - PubMed
    1. Kanas G.P., Taylor A., Primrose J.N., Langeberg W.J., Kelsh M.A., Mowat F.S., Alexander D.D., Choti M.A., Poston G. Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283–301. - PMC - PubMed

LinkOut - more resources